Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis.

Abstract

SUMMARY. In this prospective open study of 14 children with cystic fibrosis (CF), we evaluated the effect of 1 year adjuvant therapy with lansoprazole, a proton pump inhibitor (PPI), on growth, fecal fat loss, body composition and lung function. Only stable patients with pancreatic insufficiency were included, and their data were compared to those of a… (More)

Topics

Cite this paper

@article{Hendriks2001ChangesIP, title={Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis.}, author={Jerome J A Hendriks and Arnold D. M. Kester and Raymond A. M. G. Donckerwolcke and P. Ph. Forget and Edwin Wouters}, journal={Pediatric pulmonology}, year={2001}, volume={31 1}, pages={59-66} }